GlassScriptPhysician profile
Jon D Oliverio
NPI 1710985163
$5,625.06
in general payments reported to CMS, 2019-2025
31 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,378 · 2020: $597 · 2021: $1,022 · 2022: $182 · 2023: $44.28 · 2024: $287 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $3,462.24 | 2019-2021 | |
| Smith+Nephew, INC. | $680.62 | 2019-2025 | Collagenase Santyl |
| Melinta Therapeutics, LLC | $548.47 | 2019-2022 | |
| Polynovo North America LLC | $155.45 | 2024-2025 | Novosorb Btm |
| Mimedx Group, INC. | $123.01 | 2024 | |
| Treace Medical Concepts, INC. | $55.04 | 2022-2023 | |
| Medline Industries LP | $47.89 | 2019 | |
| Integra Lifesciences Corporation | $46.26 | 2020-2021 | |
| Alfasigma USA, INC. | $43.90 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $39.06 | 2021-2022 | |
| Rock Medical Orthopedics, INC. | $37.33 | 2019 | |
| Misonix INC | $34.24 | 2020 | |
| Osteomed LLC | $33.92 | 2019 | |
| Merck Sharp & Dohme LLC | $29.94 | 2019 | |
| Trice Medical, INC. | $28.24 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $21.60 | 2019 | |
| Hikma Pharmaceuticals USA | $20.98 | 2019 | |
| Tactile Systems Technology INC | $20.76 | 2024 | Entre Plus, Flexitouch Plus |
| Reprise Biomedical, INC. | $20.58 | 2024 | Miro3d |
| Kci USA, INC. | $19.86 | 2020 | |
| Convatec INC. | $19.65 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $19.37 | 2025 | |
| Ani Pharmaceuticals, INC. | $16.69 | 2025 | Purified Cortrophin Gel |
| Osiris Therapeutics INC. | $14.12 | 2019 | |
| Polarityte, INC. | $14.11 | 2019 | |
| Wright Medical Technology, INC. | $13.82 | 2020 | |
| Horizon Therapeutics Plc | $13.72 | 2021 | |
| Orthofix Medical, INC. | $13.23 | 2024 | Physio-Stim |
| Zyla Life Sciences, INC. | $11.71 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.18 | 2021 | |
| Aroa Biosurgery Incorporated | $8.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Oliverio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.